K Pharma (TSE:4896) OCF Margin %: 0.00% (As of Dec. 2025)


TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円704.00
! 1 Warning Sign
View Full Analysis

What is K Pharma OCF Margin %?

K Pharma TSE:4896 +9.15% 11 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 958 Biotechnology companies, K Pharma ranks worse than 104384.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. K Pharma's Cash Flow from Operations for the three months ended in Dec. 2025 was 円0.00 Mil. K Pharma's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, K Pharma's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, K Pharma's current OCF Yield % is -11.22%.

The historical rank and industry rank for K Pharma's OCF Margin % or its related term are showing as below:


During the past 5 years, the highest OCF Margin % of K Pharma was 45.44%. The lowest was 45.44%. And the median was 45.44%.

TSE:4896's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

K Pharma OCF Margin % Related Terms

K Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for K Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma OCF Margin % Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
0.00 0.00 45.44 0.00 0.00

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4896
11GF Score
K Pharma Inc TSE:4896
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

K Pharma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-918.005/0
= %

K Pharma's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
K Pharma (TSE:4896) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on K Pharma and its competitors. Over the past decade, K Pharma's OCF Margin % has ranged from 45.44 to 45.44. According to the industry distribution chart, K Pharma ranks #999999 out of 958 companies in the Biotechnology industry.
Is K Pharma's OCF Margin % too high?
K Pharma's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 45.44 to a high of 45.44. Based on the distribution chart, K Pharma ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, K Pharma ranks #999999 out of 958 companies for OCF Margin %. This places K Pharma in the lower half of its industry. Historically, K Pharma's own OCF Margin % has ranged from 45.44 to 45.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on K Pharma and its competitors. K Pharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For K Pharma (TSE:4896), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円704.00
Price